Polaprezinc
- Generic Name
- Polaprezinc
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H12N4O3Zn
- CAS Number
- 107667-60-7
- Unique Ingredient Identifier
- 0WA1B15A1Z
- Background
Polaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers . It was determined that polaprezinc may be effective in pressure ulcer treatment . A study in 2013 showed that CO-administration of polaprezinc may be effective against small intestine mucosal injury associated with long-term aspirin therapy .
- Indication
Peptic ulcer disease, dyspepsia .
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Zinc L-Carnosine Mouth Rinse
Phase 3
- Conditions
- PainPeriodontal Index
- Interventions
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- University of Milan
- Target Recruit Count
- 75
- Registration Number
- NCT04430998
- Locations
- ๐ฎ๐น
UOC Maxillofacial Surgery and Odontology, University of Milan, Milan, Lombardy, Italy
The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer
Not Applicable
Completed
- Conditions
- Gastric AdenomaEarly Gastric Cancer
- Interventions
- First Posted Date
- 2014-09-18
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 153
- Registration Number
- NCT02243618
- Locations
- ๐ฐ๐ท
Sevrance hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath